Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000710276 | SCV000203714 | uncertain significance | not provided | 2017-08-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000464514 | SCV000542678 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710276 | SCV000616075 | uncertain significance | not provided | 2017-07-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621883 | SCV000737323 | likely benign | Cardiovascular phenotype | 2019-12-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000710276 | SCV000980541 | likely benign | not provided | 2020-11-17 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001798493 | SCV002042470 | uncertain significance | Cardiomyopathy | 2019-07-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000710276 | SCV003827346 | uncertain significance | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing |